Johnson & Johnson(JNJ) - Stock detail

Johnson & Johnson

US
JNJ
Johnson & Johnson(Listing date: 09/25/1944)

Johnson & Johnson was incorporated in New Jersey in 1887. Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacturing and sale of various products in the healthcare field. Johnson & Johnson is a holding company, with its operating companies located in nearly all countries around the world. The company's primary focus is on products related to human health and well-being. The company is divided into two business segments: Innovative Medicine and MedTech.

🎯 Johnson & Johnson (JNJ) 📊 Analysis Report 📅 Generated: 2026-06-03 17:40:54 ET 📅 Data Analysis Range

• Analysis Period: 2026-03-10 to 2026-06-03 • Calendar Days: 86 days • Trading Records: 60 trading days • Requested Range: 60 trading days

📊 Stock Basic Information

  • Company Name: Johnson & Johnson
  • Stock Symbol: JNJ
  • Market: US Stock Market
  • Analysis Date: 2026-06-04 (Based on data up to 2026-06-03)

📈 Technical Indicator Analysis

Based on the provided real-time data, the technical indicators for JNJ as of the latest trading date (2026-06-03) paint a picture of a stock under significant selling pressure and in a defined downtrend.

Moving Averages (MAs): The moving averages are in a clear bearish alignment. The long-term 60-day MA ($233.07) is positioned above all shorter-term averages, confirming the overarching downtrend. The current price of $223.24 is trading below all key moving averages: the 5-day MA ($225.15), 10-day MA ($228.26), and 20-day MA ($227.18). This configuration, where shorter-term MAs are below longer-term ones, is a classic “death cross” pattern indicative of bearish momentum. The Exponential Moving Averages (EMAs) tell a similar story, with the price below the EMA_5 ($224.93), EMA_10 ($226.53), and EMA_20 ($227.66).

MACD (Moving Average Convergence Divergence): The MACD line is at -1.4281, the signal line is at -0.9970, and the histogram (MACDH) is negative at -0.4311. A negative MACD value indicates that the short-term momentum is weaker than the long-term momentum. While the histogram is negative, its value is not at an extreme low, suggesting the bearish momentum, while present, may not be accelerating aggressively at this precise moment. However, the MACD line being below the signal line remains a sell signal.

RSI (Relative Strength Index): The RSI_6 (6-period) is at a very oversold level of 31.05, while the standard 14-period RSI is at 40.25. An RSI below 30 is typically considered oversold, and the RSI_6 is flirting with this territory. The standard RSI at 40.25 is in bearish territory but not yet oversold. This divergence suggests that while short-term selling may be exhausted (as indicated by the oversold RSI_6), the broader momentum remains negative.

Bollinger Bands: The current price ($223.24) is trading below the middle band (20-day SMA of $227.18) and is much closer to the lower band ($219.16). Trading near the lower Bollinger Band often indicates an oversold condition and can sometimes precede a technical bounce towards the middle band. The width of the bands (Upper $235.20 - Lower $219.16 = $16.04) suggests moderate volatility.

KDJ Indicator: The KDJ values are bearish. The K value (24.07) and D value (37.04) are both below 50, signaling bearish momentum. The J value is deeply negative at -1.86, which is a strong oversold signal. Historically, such a low J value can precede a short-term reversal, but it requires confirmation from price action.

Other Indicators:

  • ATR (Average True Range): At 4.13, it quantifies the recent daily volatility. This level of volatility is consistent with the observed price swings in the data.
  • Williams %R: At -83.63, it is deep in the oversold territory (below -80), reinforcing the signals from RSI and KDJ.
  • CCI (Commodity Channel Index): At -148.28, it is far below the -100 threshold, confirming a strong bearish trend.
  • ADX (Average Directional Index): At 23.42, it suggests a weak to moderate trend strength. An ADX above 25 is generally considered a strong trend; the current reading indicates the downtrend exists but is not exceptionally powerful.
  • MFI (Money Flow Index): At an extremely low 0.37, this indicates very strong selling pressure and net outflows of money from the stock over the observed period.

📉 Price Trend Analysis

Overall Trend: The 60-day data unequivocally shows a sustained downtrend for Johnson & Johnson (JNJ). The stock has declined from a high near $247 in early April 2026 to a low near $220 by early June 2026. The series of lower highs and lower lows is the textbook definition of a bearish trend.

Recent Price Action (Last 5 Days): The recent price action from $230.80 on 2026-05-28 to $223.24 on 2026-06-03 shows a consolidation at a lower level after a sharp drop on 2026-05-29 (to $225.33 on high volume). The price has found a temporary base between $222 and $224 over the last three sessions, but it remains below all key moving averages.

Support and Resistance Levels:

  • Immediate Support: The most recent low of $220.84 (2026-06-01) and the Bollinger Band lower limit of $219.16 form the primary support zone. A break below this could trigger further selling.
  • Secondary Support: Looking at the historical data, the $224-$225 area (tested multiple times in early May) has now turned into a resistance zone. The next stronger support would be in the $215-$218 range, extrapolated from the trend.
  • Immediate Resistance: The first major resistance is the cluster of moving averages between $225 (MA_5) and $228 (MA_10/20). The psychological level of $230 and the 20-day EMA ($227.66) will be significant hurdles for any rally.
  • Strong Resistance: The $233-$235 zone, represented by the 60-day MA ($233.07) and the Bollinger Band upper limit ($235.20), is the key resistance for any trend reversal attempt.

Volume Analysis: Volume has been revealing. Notable spikes in volume occurred on:

  1. 2026-03-20: High volume (17.15M shares) accompanied a significant down day, suggesting institutional selling.
  2. 2026-04-21 & 2026-04-22: High volume on down days, confirming selling pressure during the April decline.
  3. 2026-05-15 & 2026-05-29: Both were high-volume down days (11.23M and 13.72M shares respectively), indicating strong selling conviction and potential capitulation. The elevated volume on down days versus relatively subdued volume on up days (e.g., the bounce from 2026-05-12 to 2026-05-14) is a classic bearish volume signature, where selling is driven by urgency and buying is tentative.

Chip Distribution Analysis (Estimated):

  • Methodology Note: The chip distribution data is a statistical estimate based on historical OHLC and turnover behavior. It uses a volume-based proxy to model turnover when precise rate data is unavailable. It is intended for analyzing cost concentration and should not be interpreted as exact shareholder holding data.
  • Interpretation: The estimated average cost is $228.21, which is above the current price of $223.24. This aligns with the “Profit ratio” of 23.95%, meaning approximately 76% of estimated holders are currently at a loss. This creates a potential “overhead supply” of sellers waiting to break even, which can cap upward moves.
  • The 70% cost concentration range is tight at 1.72% ($223.18 to $231.01), and the 90% range is 2.58% ($222.06 to $233.81). The current price sits at the very bottom of the 70% range and within the lower bound of the 90% range. This high concentration near the current price suggests a pivotal area; a sustained break below $222 could trigger stop-losses from this concentrated cohort, while a hold above it could lead to consolidation.

💭 Investment Recommendations

Technical Outlook: The technical evidence is overwhelmingly bearish for Johnson & Johnson (JNJ). The stock is in a confirmed downtrend, trading below all key moving averages, with momentum indicators (MACD, RSI, CCI) in bearish territory. While short-term oscillators (RSI_6, Williams %R, KDJ J-value) suggest the stock is oversold and a technical bounce is possible, the primary trend remains down. Any rally is likely to face stiff resistance at the moving average cluster ($225-$228) and the estimated high-concentration cost zone.

Recommendation: Sell / Strong Hold (for existing holders seeking to preserve capital). For investors not currently holding JNJ, the technical picture advises against initiating new long positions. The trend is your friend, and it is currently pointing down. For existing holders, the deep oversold conditions might argue for holding through a potential bounce, but the predominant evidence suggests weakness. A prudent strategy would be to use any oversold bounce towards the $228-$230 resistance zone as an opportunity to reduce exposure or implement a stop-loss.

Key Risk Warnings:

  1. Trend Continuation Risk: The primary risk is the continuation of the established downtrend, with the next target likely being a test of the $219 (lower Bollinger Band) and potentially $215 support levels.
  2. False Reversal Risk: Any bounce from oversold levels should be treated with caution unless it is accompanied by a significant increase in buying volume and a decisive close above the 20-day moving average (currently ~$227.66).
  3. Market & Sector Risks: As a large-cap healthcare stock, JNJ is subject to broader market sentiment and sector-specific news (litigation, regulatory, pipeline updates) that can override technical patterns.
  4. Limitation of Chip Data: The chip distribution analysis is an estimate. Actual holder behavior may differ from the modeled cost concentrations.

Actionable Levels:

  • For Sellers/Short-term Traders: Consider rallies towards $228-$230 as potential selling opportunities. A confirmed break below $219 (lower Bollinger Band) could signal a new leg down.
  • For Potential Buyers: Wait for a confirmed trend reversal signal. This would require a strong volume-backed close above the 20-day EMA ($227.66) and preferably a move above the 60-day MA ($233.07). Until then, the bias remains to the downside.
  • Stop-Loss Consideration: For any remaining long positions, a close below the recent low of $220.84 could serve as a final stop-loss trigger. ✅ Analysis Complete